Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

October 14, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 25, 2025

Conditions
Diabetic Foot UlcerVenous Leg Ulcer
Interventions
OTHER

Amnion-Intermediate-Chorion

Dehydrated human placental multilayer allograft from derived donated human tissue. AIC contains amnion and chorion layers as well as basement membrane and trophoblast.

OTHER

Amnion-Chorion-Amnion

Dehydrated human placental trilayer allograft derived from donated human tissue.

PROCEDURE

Standard of Care

Standard of care is to establish a clean, healthy wound bed and optimize the wound environment to have the best chance of healing the wound. This is achieved through wound cleansing, debridement, offloading and moisture balance.

Trial Locations (4)

32257

Symphony Research, Jacksonville

45249

Sure Step Foot & Ankle, Cincinnati

53142

Family Foot & Ankle, Kenosha

78596

RGV Wound Care Group, Weslaco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

SerenaGroup, Inc.

NETWORK

collaborator

LifeCell

INDUSTRY

lead

Cellution Biologics

INDUSTRY

NCT06562296 - Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers | Biotech Hunter | Biotech Hunter